SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Auric Goldfinger's Short List -- Ignore unavailable to you. Want to Upgrade?


To: Mike M who wrote (4002)11/5/1999 3:23:00 PM
From: marketmover  Read Replies (1) | Respond to of 19428
 
Mike M - the world sure looks good thro those rose colored glasses, huh?

No sellers? - but your "long term" holders just dumped 250k of 4mm and can no longer margin up.

New buyers? - please . . . the activity last week was a pure short squeeze orchestrated by Kimberly.

Zicam is doing wonderful? THE PRODUCT HAS NOT BEEN LAUNCHED YET.



To: Mike M who wrote (4002)11/5/1999 5:37:00 PM
From: RockyBalboa  Read Replies (3) | Respond to of 19428
 

Two things: (1)This stock can no longer be purchased on margin at GNLN as it is a significant holding for a rather small brokerage firm.


Ahaa! Is this the version of call in your certs,modified?

With good reason, some brokerages set the stock to nomargin. But not of what you think it maybe.

GNLN took CMVT from 5 to 100 plus.... :

Another think-in-kind: "This can be the next Microsoft". Thanks!



To: Mike M who wrote (4002)11/5/1999 6:50:00 PM
From: Sir Auric Goldfinger  Read Replies (2) | Respond to of 19428
 
CMVT was a Stuart James Deal. Next. Your info is late and wrong. If you know these guys (GNLN) as well as you say you do, well then, you know they are ex-Sovereign brokers and well, we know what that makes you.



To: Mike M who wrote (4002)11/6/1999 11:14:00 PM
From: Anthony@Pacific  Respond to of 19428
 
A@P<--independant study on nasal sparay concludes definatavely that :

owning this tock affetcts the sensory neurons and causes uncontrollable and sever reactions t o criticism of market valuations.

In addition the spray caused purple and malignant tumour growth in the frontal lobe of all 13 patients who owned stock in SNRS, with the exception of Dr Kelman, who grew a third arm and two new pockets in his polyester Ktel purchased suit